FDG PET-CT of genitourinary and gynecologic tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis

2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography (FDG PET) performed concurrently with computed tomography (CT) is central to the care of patients with advanced solid cancers. The combined FDG PET-CT exam (PET-CT) serves to provide comprehensive evaluation of tumor extent in primary treatment planning and plays an important role in accurately detecting recurrent disease during follow-up. Patients with genitourinary and gynecologic malignancies pose a unique challenge in PET-CT imaging as the majority of the tumor burden, especially at initial presentation, involves the abdomen and pelvis.

Source: Seminars in Roentgenology - December 30, 2015 Category: Radiology Authors: Leslie K. Lee, Aoife Kilcoyne, Shlomit Goldberg-Stein, David Z. Chow, Susanna I. Lee Source Type: research